Quest Diagnostics Inc. (DGX) insider trading

{
  "status": "OK",
  "results": [
    {
      "tickers": [
        "DGX"
      ],
      "issuer_cik": "0001022079",
      "owner_cik": "0001599837",
      "accession_number": "0001599837-26-000007",
      "form_type": "4",
      "filing_date": "2026-09-03",
      "period_of_report": "2026-09-01",
      "issuer_name": "QUEST DIAGNOSTICS INC",
      "issuer_trading_symbol": "DGX",
      "owner_name": "Davis J. E.",
      "is_director": true,
      "is_officer": true,
      "is_ten_percent_owner": false,
      "is_other": false,
      "officer_title": "CEO and President",
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": true,
      "transaction_date": "2026-09-01",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 10000,
      "transaction_price_per_share": 242.72,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 122423,
      "transaction_value": 2427200,
      "not_subject_to_section_16": false,
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F1",
          "description": "This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person."
        }
      ]
    },
    {
      "tickers": [
        "DGX"
      ],
      "issuer_cik": "0001022079",
      "owner_cik": "0001222679",
      "accession_number": "0001022079-26-000089",
      "form_type": "4",
      "filing_date": "2026-08-31",
      "period_of_report": "2026-08-28",
      "issuer_name": "QUEST DIAGNOSTICS INC",
      "issuer_trading_symbol": "DGX",
      "owner_name": "PREVOZNIK MICHAEL E",
      "is_director": false,
      "is_officer": true,
      "is_ten_percent_owner": false,
      "is_other": false,
      "officer_title": "SVP & General Counsel",
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": true,
      "transaction_date": "2026-08-28",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 6237,
      "transaction_price_per_share": 243.6275,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 37987,
      "transaction_value": 1519504.7175,
      "not_subject_to_section_16": false,
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F1",
          "description": "This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person."
        },
        {
          "id": "F3",
          "description": "This transaction was executed in multiple trades at prices ranging from $243.270 to $244.225.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."
        }
      ]
    }
  ]
}

// trimmed to 2 results

The response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.